Clinical Trials Logo
  1. Home
  2. Peripheral Nerve Injuries
  3. NCT04789044

Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)

Peripheral Nerve Injuries Clinical Trial

Official title:
A Phase 2a Multicenter Randomized Controlled Trial Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion) Compared to Standard of Care in the Repair of Mixed Motor-sensory Acute Peripheral Nerve Injuries (PNI) for Rapid and Immediate Improvement in Outcome

Clinical Trial Summary

The overall objective of this study is to determine the safety of PEG fusion when used with primary repair or reconstruction in patients with an acute upper extremity peripheral nerve injury. PEG is safe and effective for extending the half-life of circulating pharmaceutical products, when used in conjunction with a topical hemostatic agent in surgical wounds, and when used as a colon cleanser for endoscopic surgical procedures. However, PEG fusion has not been rigorously tested as a safe reagent to promote nerve regeneration in humans. Therefore, the goal of this Phase 2a clinical trial is to establish safety data and to examine the effect of PEG fusion on clinical outcomes including recovery of sensory and motor function. Results will be externally validated using data collected in the DoD funded prospective NERVE study and will provide preliminary evidence to power a larger phase II efficacy trial.

Clinical Trial Description

The study will enroll 40 patients receiving autograft reconstruction within 24 hours of injury. Patients will be randomized to either PEG mediated reconstruction (n=20); or conventional nerve reconstruction (n=20). The investigators hypothesize that (1) the rate of complications within 1 month of surgery in patients treated with PEG fusion will be comparable to that of patients treated with conventional autograft reconstruction, (2) there will be no detrimental effects from PEG fusion on nerve regeneration over 2 years compared to patients treated with conventional nerve reconstruction, ((3) recovery of sensory and motor function will occur earlier (within 6 months) among patients treated with PEG fusion compared to patients treated with conventional autograft reconstruction (4) patients treated with PEG fusion will have better range of motion, greater hand strength, less disability, less pain, and higher rates of treatment satisfaction compared with patients treated with conventional autograft reconstruction. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04789044
Study type Interventional
Source Major Extremity Trauma Research Consortium
Contact Elizabeth Wysocki, MS
Phone 410-955-0396
Email ewysock2@jhu.edu
Status Recruiting
Phase Phase 2
Start date June 1, 2023
Completion date October 1, 2024
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04572906 - Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries Phase 2
Active, not recruiting NCT03999424 - Autologous Human Schwann Cells in Peripheral Nerve Repair Phase 1
Not yet recruiting NCT05848778 - Non-invasive Therapy to Drive Nerve Regeneration N/A
Completed NCT02070367 - Somatosensory Assessment and Rehabilitation of Allodynia (SARA) N/A
Recruiting NCT03205124 - The Effect of Pre-operative Electrical Stimulation on Peripheral Nerve Regeneration. Phase 2/Phase 3
Recruiting NCT01526681 - Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
Recruiting NCT03422107 - Somatosensory Evoked Potential (SSEP) Monitoring for Detection of Intraoperative Positional Neuropraxia N/A
Active, not recruiting NCT05339594 - REINVENT Registry (Registry of the Nerve Gap Repair From Integra)
Completed NCT02437695 - Robot Assisted Radical Prostatecomy and Positional Injury N/A
Completed NCT02786888 - Prospective Comparison of Adductor Canal Block Performed With a Multiport Versus Single Bevel Needle N/A
Completed NCT01954199 - The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain N/A
Withdrawn NCT02095899 - Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome Phase 2
Recruiting NCT02403661 - Electrical Stimulation to Enhance Peripheral Nerve Regeneration N/A
Completed NCT03191032 - Early Sensory Re-education of the Hand With a Sensor Glove Model N/A
Recruiting NCT06209801 - Mirror Therapy Integrated With Electrical Stimulation for Cortical Modulations N/A
Recruiting NCT03913689 - StimRouter Registry Clinical Protocol
Terminated NCT02459015 - Performance Study of an Artificial Nerve Guide (Reaxon® Nerve Guide) to Treat Digital Nerve Lesions N/A
Recruiting NCT03780855 - Preliminary Evaluation of the Clinical Safety and Effectiveness of the Bionic Nerve Scaffold N/A
Recruiting NCT05884125 - Promoting Healing of Injured Nerves With Electrical Stimulation Therapy N/A
Recruiting NCT05611983 - Experience and Feasibility of Methods for Early Sensory Training N/A